GEMCITABINE / PLATINUM VS. VINORELBINE- PLATINUM IN PATIENTS WITH ADVANCED NON- SMALL- CELL LUNG CANCER
Background: A platinum- based doublets with a third- generation agents /Gemcitabine, Vinorelbine/ represent the standard first- line treatment for advanced patients with non- small- cell lung cancer /NSCLC/ and good performance status. Aim: The aim of this study was to evaluate the two commonly used...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Peytchinski Publishing
2008-09-01
|
| Series: | Journal of IMAB |
| Subjects: | |
| Online Access: | https://www.journal-imab-bg.org/statii-08/vol08_1_51-54str.pdf |